Catabasis Pharmaceuticals Insider Trades

CATB

Track insider trading activity from Catabasis Pharmaceuticals executives and directors. See which insiders are buying and selling CATB stock.

Trades Last 12 Months

All Insider Trades for Catabasis Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Violin Jonathan Director
Holding Value $0 0 shares
Last Trade
Sep 20, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.25M 263,321 shares
$8.54
$8.54
Harshbarger Benjamin Secretary And General Counsel
Holding Value $1.71M 200,000 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.59M 200,000 shares
$12.96
$8.54
Beck Joanne T. Director
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Callori Fred Director
Holding Value $726k 85,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.04M 85,000 shares
$12.24
$8.54
Clauser Noah Chief Financial Officer
Holding Value $5.12M 600,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.34M 600,000 shares
$12.24
$8.54
Cole Hugh M Director
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Bate Kenneth Director
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Komjathy Andrew Chief Commercial Officer
Holding Value $5.12M 600,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.34M 600,000 shares
$12.24
$8.54
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Milne Jill C. CEO And President
Holding Value $12M 1,400,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 1,400,000 shares
$12.24
$8.54
Nichols Andrew John Chief Scientific Officer
Holding Value $5.12M 600,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.34M 600,000 shares
$12.24
$8.54
Holding Value $264k 30,920 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 4,851 shares
$21.84
$8.54
Adelman Burt A Director
Holding Value $64.1k 7,500 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 7,500 shares
$37.02
$8.54
Donovan Joanne M. Cmo; SVP Clinical Development
Holding Value $512k 60,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 60,000 shares
$31.92
$8.54
Cunnane Deirdre A. Chief Legal Officer
Holding Value $342k 40,000 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 40,000 shares
$26.34
$8.54
Ross Michael Jay Director
Holding Value $120k 14,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 14,000 shares
$88.80
$8.54
George Jean Director
Holding Value $120k 14,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 14,000 shares
$88.80
$8.54
Hibben Edward K. Chief Business Officer
Holding Value $854k 100,000 shares
Last Trade
Feb 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.68M 100,000 shares
$76.80
$8.54
Modi Rick Chief Business Officer
Holding Value $384k 45,000 shares
Last Trade
Sep 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6M 45,000 shares
$258.42
$8.54

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up